Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.
Ferreri, Andrés J M
Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum. [electronic resource] - Blood advances 03 2020 - 1013-1019 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
2473-9537
10.1182/bloodadvances.2020001459 doi
Adult
Conjunctiva
Humans
Lymphoma, B-Cell, Marginal Zone--drug therapy
Neoplasm Recurrence, Local
Prospective Studies
Rituximab
Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum. [electronic resource] - Blood advances 03 2020 - 1013-1019 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
2473-9537
10.1182/bloodadvances.2020001459 doi
Adult
Conjunctiva
Humans
Lymphoma, B-Cell, Marginal Zone--drug therapy
Neoplasm Recurrence, Local
Prospective Studies
Rituximab